LIXTE Biotechnology Transforms into AI Energy Infrastructure Company, Adds Denham Capital Founder to Board

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced a strategic transformation into an AI energy infrastructure equipment and services platform, targeting the growing power demands of artificial intelligence and hyperscale data centers. As part of this shift, Stuart D. Porter, founder, managing partner, CEO and chief investment officer of Denham Capital Management LP, has joined the company’s board of directors, according to a press release.

The company’s new strategy will focus on power equipment and service solutions for AI data-center campuses, distributed power systems and advanced generation technologies. LIXTE also stated it is seeking a strategic acquisition partner for its clinical-stage pharmaceutical and med-tech operations, which are centered on cancer treatments.

This pivot comes as the energy demands of AI and data centers are expected to surge, creating opportunities for infrastructure providers. By bringing in Porter, whose firm Denham Capital has deep experience in energy and infrastructure investments, LIXTE gains expertise in scaling energy-focused businesses.

LIXTE’s legacy operations include its lead compound LB-100, a first-in-class PP2A inhibitor that has shown promise in enhancing chemotherapies and immunotherapies. The company also owns Liora Technologies Europe Ltd., which is developing the LiGHT System for proton therapy. However, the company is now seeking a partner to advance these assets while it redirects its corporate focus.

The announcement highlights a trend of biotechnology companies pivoting to high-growth sectors like AI infrastructure, leveraging their public listing and capital to enter new markets. LIXTE’s move could provide a pathway to monetize its drug development assets while capitalizing on the AI boom.

For more details, the full press release is available at https://ibn.fm/MVXfg. Additional information about LIXTE can be found at www.lixte.com, and about Liora Technologies at www.lioratechnologies.com.

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is LIXTE Biotechnology Transforms into AI Energy Infrastructure Company, Adds Denham Capital Founder to Board.

The post LIXTE Biotechnology Transforms into AI Energy Infrastructure Company, Adds Denham Capital Founder to Board appeared first on citybuzz.